Valuation: Revvity, Inc.

Market Cap 16.01B 81.8B 13.96B 13.14B 11.97B 22.44B 1,534B 22.47B 157B 60.67B 781B 60.13B 58.8B 2,521B P/E 2026 *
60.5x
P/E 2027 * 47.5x
Enterprise Value 17.99B 91.94B 15.69B 14.78B 13.46B 25.23B 1,724B 25.26B 177B 68.2B 878B 67.59B 66.09B 2,833B EV / Sales 2026 *
6.31x
EV / Sales 2027 * 5.81x
Free-Float
99.73%
Yield 2026 *
0.2%
Yield 2027 * 0.19%
1 day+3.00%
3 months+11.47%
6 months+28.75%
Current year+10.16%
Current year 14.91
Extreme 14.91
22.24
1 year 14.91
Extreme 14.91
22.24
3 years 14.51
Extreme 14.51
26.28
5 years 14.51
Extreme 14.51
39.55
10 years 11.96
Extreme 11.957142
39.55
Manager TitleAgeSince
Chief Executive Officer 61 2019-12-29
Director of Finance/CFO 37 2022-09-05
Chief Tech/Sci/R&D Officer - 2023-04-30
Director TitleAgeSince
Chairman 68 2019-12-29
Director/Board Member 74 2012-02-06
Director/Board Member 72 2016-07-26
Change 5-day change 1-year change 3-year change Capi.($)
+3.00%-.--% - - 16.01B
+0.82%+6.79%+37.96%+30.65% 241B
+1.06%+5.20%+12.26%-14.35% 149B
+1.53%+5.67%-10.17%+40.45% 139B
-0.18%-4.12%-55.48%-19.96% 62.81B
+0.24%+3.45%+19.96%+26.06% 50.87B
+0.53%-2.62%-19.06%-16.99% 48.21B
+3.58%+10.32%+28.19%+47.58% 44.11B
+0.59%+3.25%+39.96%+57.46% 41.42B
+0.94%+16.14%+138.27%+81.37% 36.18B
Average +1.21%+5.47%+21.32%+25.81% 90.26B
Weighted average by Cap. +1.04%+5.73%+17.32%+21.59%

Financials

2026 *2027 *
Net sales 2.85B 14.57B 2.49B 2.34B 2.13B 4B 273B 4B 28.04B 10.81B 139B 10.71B 10.47B 449B 3B 15.35B 2.62B 2.47B 2.25B 4.21B 288B 4.22B 29.55B 11.39B 147B 11.29B 11.04B 473B
Net income 273M 1.39B 238M 224M 204M 383M 26.15B 383M 2.68B 1.03B 13.32B 1.03B 1B 42.98B 337M 1.72B 294M 277M 252M 473M 32.33B 474M 3.32B 1.28B 16.47B 1.27B 1.24B 53.14B
Net Debt 1.99B 10.15B 1.73B 1.63B 1.48B 2.78B 190B 2.79B 19.53B 7.53B 96.89B 7.46B 7.29B 313B 1.46B 7.45B 1.27B 1.2B 1.09B 2.05B 140B 2.05B 14.35B 5.53B 71.19B 5.48B 5.36B 230B
Logo Revvity, Inc.
Revvity, Inc. specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales break down by family of products as follows: - medical diagnosis equipment (50.1%); - analytical tools and instruments (49.9%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc. Net sales break down by source of revenue between sales of products (83.7%) and services (16.3%). Net sales are distributed geographically as follows: America (44%), Europe (28.9%) and Asia (27.1%).
Employees
11,000
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
143.45USD
Average target price
128.47USD
Spread / Average Target
-10.44%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!